论文部分内容阅读
一种改进的来自女性卵母细胞的核DNA转移到供者卵母细胞的方法可能导致人们开发出一种更加有效的线粒体替代疗法(mitochondrialreplacementtherapy,MRT),这可能能够降低将线粒体DNA(mitochondriaDNA,mtDNA)疾病传递给后代
An improved method of transferring nuclear DNA from female oocytes to donor oocytes may lead to the development of a more effective mitochondrial replacement therapy (MRT) that may reduce the risk of introducing mitochondria DNA mtDNA) disease to offspring